SignatureFD
MRVI icon

SignatureFD’s Maravai LifeSciences MRVI Stock Holding History

SignatureFD’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$93.2K Hold
12,172
– – ﹤0.01% 1597
2026
Q2 		$76K Sell
12,172
-2,126
-15% -$9.18K ﹤0.01% 1612
2026
Q1 		$40.5K Hold
14,298
– – ﹤0.01% 1850
2025
Q4 		$46.5K Buy
14,298
+475
+3% +$1.6K ﹤0.01% 1695
2025
Q3 		$39.7K Buy
13,823
+3,841
+38% +$9.8K ﹤0.01% 1762
2025
Q2 		$24.1K Buy
9,982
+4,723
+90% +$9.9K ﹤0.01% 1969
2025
Q1 		$11.6K Buy
5,259
+2,464
+88% +$9.7K ﹤0.01% 2296
2024
Q4 		$15.2K Sell
2,795
-3,625
-56% -$23.3K ﹤0.01% 2200
2024
Q3 		$53.4K Sell
6,420
-356
-5% -$3.08K ﹤0.01% 1541
2024
Q2 		$48.5K Buy
6,776
+674
+11% +$5.82K ﹤0.01% 1526
2024
Q1 		$52.9K Buy
6,102
+1,470
+32% +$9.9K ﹤0.01% 1522
2023
Q4 		$30.3K Buy
4,632
+1,268
+38% +$8.19K ﹤0.01% 1716
2023
Q3 		$33.6K Buy
3,364
+1,681
+100% +$18.5K ﹤0.01% 1599
2023
Q2 		$20.9K Sell
1,683
-3,114
-65% -$42K ﹤0.01% 1861
2023
Q1 		$67.2K Buy
4,797
+2,835
+144% +$40.7K ﹤0.01% 1238
2022
Q4 		$28.1K Buy
1,962
+760
+63% +$12K ﹤0.01% 1640
2022
Q3 		$31K Buy
1,202
+802
+201% +$20.1K ﹤0.01% 1532
2022
Q2 		$11K Hold
400
– – ﹤0.01% 2073
2022
Q1 		$14K Hold
400
– – ﹤0.01% 2006
2021
Q4 		$17K Buy
400
+200
+100% +$8.1K ﹤0.01% 1858
2021
Q3 		$10K Buy
+200
New +$9.8K ﹤0.01% 2072

Other funds holding MRVI

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
General American Investors
General American Investors New York $1.71B AUM 30.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
STRS Ohio
STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return

SignatureFD's MRVI Position: Q3 2026 in Review

SignatureFD held its Maravai LifeSciences (MRVI) position steady in Q3 2026 at 12,172 shares worth $93.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1597.

SignatureFD first reported a position in MRVI in Q3 2021 and has held it in 21 quarters since. 60 funds tracked by Wall St. Rank hold MRVI as of Q3 2026.

  • SignatureFD held 12,172 shares of Maravai LifeSciences worth $93.2K as of Q3 2026.
  • SignatureFD left its Maravai LifeSciences share count unchanged in Q3 2026.
  • Maravai LifeSciences made up ﹤0.01% of SignatureFD's portfolio in Q3 2026, its #1597 holding.
  • SignatureFD first reported a position in Maravai LifeSciences in Q3 2021 and has held it in 21 quarters since.
  • 60 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q3 2026.

Based on SignatureFD's 13F filing for Q3 2026, filed 23 Oct 2026.